HealthAugust 11, 2026
bexotegrast
bek-SO-teh-grast
Definition
An experimental drug compound that was being studied as a potential treatment for idiopathic pulmonary fibrosis (IPF) before its development was terminated by the company.
Etymology
As a proprietary pharmaceutical name, it is a constructed term likely blending chemical naming conventions (the -grast suffix is commonly used for certain classes of growth factor regulators) to identify a specific drug candidate.
In the news
The article mentions the drug's development was stopped in 2025 to explain a significant decrease in research and development expenses for the current year.
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Read the full article ↗The Manila Times